Skip to main content
. 2019 Aug;14(8):1445–1448. doi: 10.4103/1673-5374.253528

Figure 3.

Figure 3

Cost per patient with AMD or DR receiving treatment with ranibizumab from January 2014 to June 2017.

The cost per patient is quite equal in AMD and DR and it is subjected to a reduction over time. AMD: Age-related macular degeneration; DR: diabetic retinopathy.